{"entities": {"annotations": [{"start": 69, "end": 72, "probability": 0.5709, "type": "Organization", "normalized_text": "SARS"}], "mentions": [{"start": 97, "end": 107, "username": "NCDS_BBSR", "id": "3579680774"}, {"start": 110, "end": 120, "username": "HFWOdisha", "id": "825566197714403328"}, {"start": 121, "end": 132, "username": "IPR_Odisha", "id": "743517005920141314"}, {"start": 133, "end": 141, "username": "bmcbbsr", "id": "809378222697811968"}, {"start": 142, "end": 156, "username": "ICMR_RMRCBBSR", "id": "983291309799571456"}], "urls": [{"start": 157, "end": 180, "url": "https://t.co/HYHyN0hKw2", "expanded_url": "https://twitter.com/NCDS_BBSR/status/1253301630897922050", "display_url": "twitter.com/NCDS_BBSR/stat\u2026"}]}, "text": "The Odia version of the policy brief FAQs on rapid antibody test for SARS-CoV-2 is now put up by @NCDS_BBSR \n\n@HFWOdisha @IPR_Odisha @bmcbbsr @ICMR_RMRCBBSR https://t.co/HYHyN0hKw2", "reply_settings": "everyone", "in_reply_to_user_id": "53306736", "id": "1253379264126181378", "lang": "en", "possibly_sensitive": false, "referenced_tweets": [{"type": "quoted", "id": "1253301630897922050"}, {"type": "replied_to", "id": "1252255270727675904"}], "created_at": "2020-04-23T17:44:37.000Z", "public_metrics": {"retweet_count": 0, "reply_count": 1, "like_count": 1, "quote_count": 0}, "conversation_id": "1252249440443789313", "author_id": "53306736", "source": "Twitter for Android"}